$RXMD's CEO discusses the third quarter 2019 financial highlights, the outlook for the Company in 2020, the renegotiated Family Physicians Rx (FPRX) acquisition, reducing price by 36%, saving shareholders $1.1 million, and much more.

https://twitter.com/ProgressCareUS/status/119...6002489344